BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1907705)

  • 1. The role of polyols in cerebral cell volume regulation in hypernatremic and hyponatremic states.
    Trachtman H; Futterweit S; Hammer E; Siegel TW; Oates P
    Life Sci; 1991; 49(9):677-88. PubMed ID: 1907705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L; Day N; Peterson RG; Eichberg J
    Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucose.
    Karihaloo AK; Joshi K; Chopra JS
    J Neurochem; 1997 Nov; 69(5):2011-8. PubMed ID: 9349546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on rat renal osmolytes of extended treatment with an aldose reductase inhibitor.
    Edmands S; Yancey PH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Nov; 103(3):499-502. PubMed ID: 1363299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
    MacGregor LC; Matschinsky FM
    J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent aspects of osmolyte changes in rat kidney, urine, blood and lens with sorbinil and galactose feeding.
    Edmands SD; Hughs KS; Lee SY; Meyer SD; Saari E; Yancey PH
    Kidney Int; 1995 Aug; 48(2):344-53. PubMed ID: 7564101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
    Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
    Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli.
    Cohen MP; Klepser H; Cua E
    Biochim Biophys Acta; 1986 Apr; 876(2):226-32. PubMed ID: 3006784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport.
    Cammarata PR; Chen HQ
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of insulin and sorbinil on myoinositol uptake in peripheral nerve from normal and diabetic rats and a neuroblastoma cell line (N1E-115).
    Dunlop ME; Hill MA; Larkins RG
    Diabetes Res; 1988 Jun; 8(2):51-7. PubMed ID: 3147829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sorbinil on myo-inositol metabolism in cultured neuroblastoma cells exposed to increased glucose levels.
    Yorek MA; Dunlap JA; Ginsberg BH
    J Neurochem; 1988 Aug; 51(2):331-8. PubMed ID: 3392531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.